BMS Archive

Plant · Scientific monograph

Gentiana lutea

Yellow gentian

For educational and scientific research only. Not medical advice. Independently verify claims against the cited primary sources. Consult a qualified healthcare professional before using any plant or fungal preparation.

Research areas: Digestive traditional use, Topical skin research

Research overview

Historical use

EMA recognizes traditional use of specified gentian-root preparations for temporary loss of appetite and mild dyspeptic/gastrointestinal complaints [1].

Modern research context

The EMA conclusion is based on traditional use; an uncontrolled 205-person study did not support firm efficacy conclusions [1]. A 22-person, 14-day split-face study examined a topical eye-area cream, which does not support oral digestive claims [2].

Adverse effects

EMA reported no side effects in the assessment material at that time, but this is not proof of safety across products or populations [1].

Contraindications

Use only within the EMA's specified root preparations and traditional-use scope. The topical skin trial does not establish oral use [1,2].

Clinical and phytochemical data

Used part

Dried/comminuted root or specified ethanol extracts for EMA scope; separate topical extract in the skin study [1,2].

Primary active compounds

  • Gentiopicroside and other bitter secoiridoids are reported in the EMA assessment [1].

Mechanism of action

The topical study explored pathways in skin models; it does not establish a clinical mechanism for oral gentian preparations [2].

Pharmacokinetics

Absorption

EMA reports no clinical pharmacokinetic data for gentian root [1].

Distribution

No clinical PK data available [1].

Metabolism

No clinical PK data available [1].

Excretion

No clinical PK data available [1].

Safety and interactions

Drug interactions

No clinical interaction evidence sufficient to grade interactions was identified by EMA [1].

Toxicity

Clinical safety data are limited; EMA assessment is not a comprehensive long-term toxicity demonstration [1].

Special precautions

Pregnancy

EMA states use in children/adolescents under 18 is not recommended; medicinal use in pregnancy is insufficiently established [1].

Lactation

Lactation safety is not established [1].

Hepatic impairment

No hepatic impairment-specific evidence identified.

Renal impairment

No renal impairment-specific evidence identified.

Sources and references

  1. [1] EMA/HMPC. European Union herbal monograph on Gentiana lutea L., radix, revision 1. EMA/HMPC/607861/2017.
  2. [2] Jean-Yves Berthon et al. In vitro, ex vivo and clinical approaches to evaluate the potential effect of Gentiana lutea extract on skin. International Journal of Cosmetic Science. 2023;45(5):688–698. PMID: 37365865. DOI: 10.1111/ics.12878.

Additional source links

Continue browsing